Lloyd H. Smith

8.4k total citations · 1 hit paper
143 papers, 5.9k citations indexed

About

Lloyd H. Smith is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lloyd H. Smith has authored 143 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 26 papers in Pulmonary and Respiratory Medicine and 18 papers in Oncology. Recurrent topics in Lloyd H. Smith's work include Biochemical and Molecular Research (13 papers), Porphyrin Metabolism and Disorders (11 papers) and Ovarian cancer diagnosis and treatment (10 papers). Lloyd H. Smith is often cited by papers focused on Biochemical and Molecular Research (13 papers), Porphyrin Metabolism and Disorders (11 papers) and Ovarian cancer diagnosis and treatment (10 papers). Lloyd H. Smith collaborates with scholars based in United States, Sweden and Poland. Lloyd H. Smith's co-authors include Beate Danielsen, Hibbard E. Williams, Guibo Xing, Rosemary D. Cress, William M. Gilbert, Gary S. Leiserowitz, Dina El Kady, Harald Prydz, Chr. Klixbüll Jørgensen and Gunnar Hanshoff and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Lloyd H. Smith

136 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biochemistry and physiology of taurine and taurine derivatives.

1968 891 citations Lloyd H. Smith et al. profile →

Peers

Countries citing papers authored by Lloyd H. Smith

Since Specialization

Citations

This map shows the geographic impact of Lloyd H. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd H. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd H. Smith more than expected).

Fields of papers citing papers by Lloyd H. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd H. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd H. Smith. The network helps show where Lloyd H. Smith may publish in the future.

Co-authorship network of co-authors of Lloyd H. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd H. Smith. A scholar is included among the top collaborators of Lloyd H. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd H. Smith. Lloyd H. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma 2020 ·Gynecologic Oncology ·Hui Chen, (unknown), Cristabelle De Souza, Clifford G. Tepper, Anthony N. Karnezis, Gary S. Leiserowitz, Jeremy Chien, Lloyd H. Smith	50
2	The Use of Endometrial Cancer Patient-Derived Organoid Culture for Drug Sensitivity Testing Is Feasible 2017 ·International Journal of Gynecological Cancer ·Eugenia Girda, Gary S. Leiserowitz, Lloyd H. Smith, Eric C. Huang	57
3	Ovarian cancer: predictors of early-stage diagnosis 2010 ·Cancer Causes & Control ·Cyllene R. Morris, (unknown), Lloyd H. Smith	37
4	Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomes 2008 ·The Journal of Maternal-Fetal & Neonatal Medicine ·(unknown), Guibo Xing, Rosemary D. Cress, Beate Danielsen, Lloyd H. Smith	33
5	Evidence of Poorer Survival in Pregnancy-Associated Breast Cancer 2008 ·Obstetrics and Gynecology ·Anne O. Rodriguez, Helen K. Chew, Rosemary D. Cress, Guibo Xing, Sherrie S. McElvy, Beate Danielsen, Lloyd H. Smith	109
6	Thyroid cancer in pregnancy 2005 ·International Journal of Gynecology & Obstetrics ·S. Yasmeen, Rosemary D. Cress, Patrick S. Romano, Guibo Xing, (unknown), Beate Danielsen, Lloyd H. Smith	87
7	Ovarian cancer: Can we make the clinical diagnosis earlier? 2005 ·Cancer ·Lloyd H. Smith, Cyllene R. Morris, Shagufta Yasmeen, Arti Parikh‐Patel, Rosemary D. Cress, Patrick S. Romano	83
8	Maternal and Neonatal Outcomes of Assaults During Pregnancy 2005 ·Obstetrics and Gynecology ·Dina El Kady, William M. Gilbert, Guibo Xing, Lloyd H. Smith	166
9	Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population 2004 ·American Journal of Obstetrics and Gynecology ·Dina El Kady, William M. Gilbert, J.G. Anderson, Beate Danielsen, Dena Towner, Lloyd H. Smith	186
10	Cancer associated with obstetric delivery: results of linkage with the California cancer registry 2003 ·American Journal of Obstetrics and Gynecology ·Lloyd H. Smith, Beate Danielsen, Mark Allen, Rosemary D. Cress	273
11	Detection of Serologic Neutralizing Antibodies against HPV-11 in Patients with Condyloma Acuminata and Cervical Dysplasia Using anin VitroAssay 1997 ·Gynecologic Oncology ·Gary S. Leiserowitz, Kathleen Hall, (unknown), (unknown), Neil D. Christensen, K. Heim, Lloyd H. Smith	10
12	Human monoclonal antibody recognizing an antigen associatedwith ovarian and other adenocarcinomas 1992 ·American Journal of Obstetrics and Gynecology ·Lloyd H. Smith, (unknown), (unknown), Nancy K. Tyler, (unknown), (unknown), Marcia M. Bieber, Nelson N.H. Teng	1
13	Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies 1990 ·Gynecologic Oncology ·Jane E. Christman, David S. Miller, Peter Coward, Lloyd H. Smith, Nelson N.H. Teng	35
14	Clinical applications of monoclonal antibodies in gynecologic oncology 1987 ·Cancer ·Lloyd H. Smith, Nelson N.H. Teng	9
15	EFFECTS OF WIGGLERS AND UNDULATORS ON BEAM DYNAMICS 1986 ·University of North Texas Digital Library (University of North Texas) ·Lloyd H. Smith	17
16	Medical Education for the 21st Century. 1985 ·Academic Medicine ·Lloyd H. Smith	9
17	Superconducting Magnet and Cryostat for a Space Application 1974 ·eScholarship (California Digital Library) ·W.L. Pope, George F. Smoot, Lloyd H. Smith, C. Taylor	0
18	Measurement of separate electron and positron spectra in the primary cosmic rays from 5 to 50 GeV 1973 ·Rare & Special e-Zone (The Hong Kong University of Science and Technology) ·A. Buffington, G. F. Smoot, Lloyd H. Smith, C. D. Orth	1
19	PYRIMIDINE METABOLISM IN MAN. IV. THE ENZYMATIC DEFECT OF OROTIC ACIDURIA* 1961 ·Journal of Clinical Investigation ·Lloyd H. Smith, Margaret P. Sullivan, Charles M. Huguley	92
20	Inhibition of Dihydroorotase in Pyrimidine Biosynthesis 1960 ·Cancer Research ·Lloyd H. Smith, Margaret P. Sullivan, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact